Font Size:
Novartis to Acquire Slovenian Generics Company
Business Review Editor
Abstract
Novartis acquires generics manufacturer Lek in a deal worth up to CHF1.18 B. The acquisition of Lek will add a significant status to Novartis’ generics sales.
Full Text: pdf
Add comment
This work is licensed under a Creative Commons Attribution 3.0 License.